LeMaitre Vascular, Inc. (LMAT) Institutional Ownership & Insider Trading

326 institutions reported holding LeMaitre Vascular, Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 11 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

LMATLeMaitre Vascular, Inc.Follow LMAT — free

Medical Instruments & Supplies · Healthcare

—

Price chart with a free account

Market cap: 1.9B
P/E TTM: 29.6
Dividend yield: 1.1%
52-week: —
Next earnings: 4 Nov, in 11 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

326 institutions held 100.0% of the shares. Across filers that reported both quarters, shares held changed +3.4%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	326	23	+3.4%	121	29	87	41
Mar 26	337	22	+5.0%	107	55	85	18
Dec 25	295	21	+1.0%	95	19	103	20
Sep 25	292	21	-1.0%	97	33	79	12
Jun 25	281	21	+0.4%	94	22	86	23
Mar 25	282	21	-0.2%	90	20	107	35
Dec 24	302	21	+0.5%	105	23	85	19
Sep 24	287	21	-0.9%	87	39	77	13

LeMaitre Vascular, Inc. — questions

Who owns LeMaitre Vascular, Inc. stock?: 326 institutions reported LeMaitre Vascular, Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (14.3%), Conestoga Capital Advisors, LLC (6.0%), FIRST TRUST ADVISORS LP (4.8%).
Are LeMaitre Vascular, Inc. insiders buying or selling?: 11 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from LeMaitre Vascular, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.